Patents Assigned to Pharmacylics LLC
  • Inhibitors of Bruton's tyrosine kinase
    Patent number: 9556182
    Abstract: Described herein are irreversible kinase inhibitor compounds, methods for synthesizing such irreversible inhibitors, and methods for using such irreversible inhibitors in the treatment of diseases. Further described herein are methods, assays and systems for determining an appropriate irreversible inhibitor of a protein, including a kinase.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: January 31, 2017
    Assignee: Pharmacylics LLC
    Inventors: Lee Honigberg, Erik Verner, Joseph J. Buggy, David Loury, Wei Chen